Mildred Pasek

1.0k total citations
11 papers, 677 citations indexed

About

Mildred Pasek is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Mildred Pasek has authored 11 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Hematology and 7 papers in Immunology. Recurrent topics in Mildred Pasek's work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (5 papers) and Acute Myeloid Leukemia Research (4 papers). Mildred Pasek is often cited by papers focused on CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (5 papers) and Acute Myeloid Leukemia Research (4 papers). Mildred Pasek collaborates with scholars based in United States. Mildred Pasek's co-authors include Robert J. Soiffer, Edwin P. Alyea, Corey Cutler, Joseph H. Antin, Vincent T. Ho, Jerome Ritz, Sue Corringham, Israel Lowy, James R. Mason and Bridget Medina and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Biology of Blood and Marrow Transplantation.

In The Last Decade

Mildred Pasek

11 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mildred Pasek United States 4 427 377 309 111 87 11 677
Sue Corringham United States 10 255 0.6× 214 0.6× 364 1.2× 118 1.1× 57 0.7× 25 554
Ángel Ramírez Páyer Spain 12 286 0.7× 177 0.5× 263 0.9× 116 1.0× 172 2.0× 33 609
P Anderlini United States 8 202 0.5× 552 1.5× 177 0.6× 35 0.3× 136 1.6× 9 619
Eve‐Marie Neidhardt‐Berard France 7 95 0.2× 258 0.7× 246 0.8× 172 1.5× 126 1.4× 11 482
F. Dreyfus France 8 166 0.4× 326 0.9× 108 0.3× 68 0.6× 114 1.3× 18 453
S Slavin Israel 12 316 0.7× 483 1.3× 133 0.4× 33 0.3× 70 0.8× 15 648
Sharon Tindle United States 9 144 0.3× 639 1.7× 312 1.0× 48 0.4× 102 1.2× 19 742
A. R. Zander Germany 8 186 0.4× 332 0.9× 137 0.4× 131 1.2× 176 2.0× 16 555
D Thorp Australia 12 127 0.3× 621 1.6× 308 1.0× 60 0.5× 142 1.6× 15 715
Abraham Kneller Israel 6 375 0.9× 120 0.3× 458 1.5× 154 1.4× 73 0.8× 12 660

Countries citing papers authored by Mildred Pasek

Since Specialization
Citations

This map shows the geographic impact of Mildred Pasek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mildred Pasek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mildred Pasek more than expected).

Fields of papers citing papers by Mildred Pasek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mildred Pasek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mildred Pasek. The network helps show where Mildred Pasek may publish in the future.

Co-authorship network of co-authors of Mildred Pasek

This figure shows the co-authorship network connecting the top 25 collaborators of Mildred Pasek. A scholar is included among the top collaborators of Mildred Pasek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mildred Pasek. Mildred Pasek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ho, Vincent T., Matthew W. Vanneman, Haesook Kim, et al.. (2009). Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation. Proceedings of the National Academy of Sciences. 106(37). 15825–15830. 83 indexed citations
2.
Ho, Vincent T., Glenn Dranoff, Haesook Kim, et al.. (2008). GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies. Blood. 112(11). 825–825. 1 indexed citations
3.
Bashey, Asad, Bridget Medina, Sue Corringham, et al.. (2008). CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation. Blood. 113(7). 1581–1588. 270 indexed citations
4.
Bashey, Asad, Bridget Medina, Sue Corringham, et al.. (2007). Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation.. Blood. 110(11). 1646–1646. 2 indexed citations
5.
6.
Ho, Vincent T., Glenn Dranoff, Mildred Pasek, et al.. (2006). GM-CSF secreting leukemia cell vaccinations after allogeneic non-myeloablative peripheral blood stem cell transplantation in patients with advanced myelodysplastic syndrome or refractory acute myeloid leukemia. Biology of Blood and Marrow Transplantation. 12(2). 17–18. 1 indexed citations
7.
8.
9.
Cutler, Corey, David B. Miklos, Haesook T. Kim, et al.. (2006). Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 108(2). 756–762. 310 indexed citations
10.
Bashey, Asad, Bridget Medina, Sue Corringham, et al.. (2005). Phase I Study of a Neutralizing Monoclonal Anti-CTLA4 Antibody (MDX-010) in Patients with Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation.. Blood. 106(11). 2017–2017. 2 indexed citations
11.
Cutler, Corey, David B. Miklos, Stephanie J. Lee, et al.. (2004). Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.. Blood. 104(11). 2251–2251. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sue Corringham Breakdown of academic impact, for papers by Ángel Ramírez Páyer Breakdown of academic impact, for papers by P Anderlini Breakdown of academic impact, for papers by Eve‐Marie Neidhardt‐Berard Breakdown of academic impact, for papers by F. Dreyfus Breakdown of academic impact, for papers by S Slavin Breakdown of academic impact, for papers by Sharon Tindle Breakdown of academic impact, for papers by A. R. Zander Breakdown of academic impact, for papers by D Thorp Breakdown of academic impact, for papers by Abraham Kneller
Rankless by CCL
2026